查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967687

硫酸软骨素市场－全球产业规模、份额、趋势、机会、预测：按原料、应用、区域和竞争对手划分，2021-2031年

Chondroitin Sulfate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球硫酸软骨素市场预计将从 2025 年的 11.1 亿美元成长到 2031 年的 13.5 亿美元，复合年增长率为 3.32%。

硫酸软骨素是一种硫酸化的Glico，是软骨的基本结构成分。它广泛用于药物製剂和营养补充剂中，以维持关节活动度和组织健康。全球人口老化和骨关节炎发病率上升是推动该市场成长的主要因素，这加速了消费者向预防医学和非侵入性关节管理方式的转变。营养策略在促进身体健康方面的广泛应用也支撑了这项需求。根据美国消费者保健产品协会 (CHPA) 2025 年的调查，83% 的受访者使用营养补充品来维持健康，这为关节健康产品创造了非常有利的市场环境。

市场概览
预测期 2027-2031
市场规模：2025年 11.1亿美元
市场规模：2031年 13.5亿美元
复合年增长率：2026-2031年 3.32%
成长最快的细分市场 动物饲料
最大的市场 亚太地区

儘管成长指标强劲，但由于高度依赖动物性原料，特别是鲨鱼和牛软骨，该市场仍面临许多障碍。这种依赖使该行业易受供应链波动风险的影响，引发具有环保意识的消费者的道德抵制，并限制了在纯素和植物来源食品盛行地区的市场扩张。此外，为防止动物性供应链中的诈欺行为而实施的严格品管，增加了生产的复杂性和成本，可能阻碍其广泛进入市场。

市场驱动因素

骨关节炎和关节疾病的日益普遍是全球硫酸软骨素市场的主要驱动力。随着全球软骨退化性疾病加剧，迫切需要能够抑制降解酶并促进蛋白聚醣合成的治疗药物。这项健康挑战使硫酸软骨素成为药物和膳食补充剂管理通讯协定的基础成分。根据2024年11月发表在《医学前沿》（Frontiers in Medicine）上的一项研究“1990-2021年全球、区域和国家骨关节炎负担”，全球骨关节炎患病率已达约6.069亿例，形成了一个庞大的患者群体，他们依赖保守的关节炎治疗。人们普遍依赖营养干预来维持身体健康，进一步推动了这项需求。根据责任营养委员会（CRN）于2024年10月发布的“2024年消费者调查”，75%的美国人使用膳食补充剂，这反映出一种持续的习惯，有利于关节健康产品类型的发展。

推动市场成长的第二个关键因素是宠物对兽用营养补充品和功能性宠物食品的需求不断增长。随着宠物饲主越来越像对待人类一样对待他们的伴侣动物，透过饮食而非侵入性手术来治疗猫狗髋关节发育不良的概念正日益受到关注。製造商们正积极响应这一需求，在高檔干粮和零食中添加软骨素，以主动解决整形外科问题，从而拓展了该成分在人类以外的应用。根据美国宠物用品协会 (APPA) 于 2024 年 8 月发布的《2024 年犬猫报告》的数据，自 2018 年以来，犬类维生素补充剂的使用量增长了近 50%，猫类增长了 60%。这一增长使原料生产商的收入来源更加多元化，并巩固了软骨素在高盈利的动物保健领域中的地位。

市场挑战

全球硫酸软骨素市场成长面临的主要挑战之一是高度依赖动物性原料，尤其是牛软骨和鲨鱼软骨。这种依赖性使生产商容易受到渔业和肉类加工业波动的影响，导致原料供应不稳定，供应链不稳定。这种不稳定性阻碍了有效的生产计画，使行业无法建立稳定的定价体系，并对长期可靠性和商业性扩充性负面影响。

此外，与动物性原料采购相关的伦理问题和严格的品质保证要求持续阻碍市场扩张。随着消费者越来越重视永续性，植物来源的市场渗透也面临挑战。此外，为确保纯度和防止动物性供应链中的诈欺行为而进行的强制性检测，显着增加了生产成本。这些增加的营运成本导致最终产品价格上涨，限制了价格敏感型消费者的购买力。责任营养委员会 (CRN) 2024 年的一项调查发现，27% 的非膳食补充剂使用者将成本列为主要障碍，这凸显了这些复杂的供应链及其导致的价格上涨如何直接阻碍市场渗透。

市场趋势

为了降低动物性成分相关的供应风险，製造商正加速采用纯素和发酵生产方法，从根本上重塑全球硫酸软骨素市场。製造商正迅速从传统的鲨鱼和牛软骨萃取物转向先进的微生物发酵技术，这些技术不仅纯度更高、均一性更强，还能满足消费者的伦理诉求。此技术转变的基础是非动物性替代品功效的显着提升。根据《营养保健品商业评论》2025年4月刊题为「MyCondro：新时代的新名称」的报告，药物动力学研究证实，Resafre公司发酵法提取的硫酸软骨素的生物利用度比标准牛来源高出45%，为高端关节健康配方树立了新的标竿。

第二个主要趋势是利用植物萃取物和胶原蛋白的协同配方日益普及。各大品牌不再局限于单一成分的软骨素补充剂，而是致力于提供全面的关节活动解决方案。业内相关人员越来越多地将硫酸软骨素等互补成分与未变性的II型胶原蛋白结合使用，以增强软骨保护并降低成品中的有效剂量。这项策略旨在最大限度地提高治疗效果，并在竞争激烈的市场中实现产品差异化。 BioIberica公司于2025年11月发布的《2025年全球供应端：Coravant n2与关节健康》报告中详细介绍了一项新的临床研究，该研究表明，该公司协同作用的胶原蛋白成分可将软骨保护提高40%。这印证了市场对多方面关节健康系统（而非单一软骨素疗法）日益增长的需求。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球硫​​酸软骨素市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依原料分类（牛来源、禽肉来源、合成材料、猪肉来源、鲨鱼来源）
    • 按应用领域（营养补充品、个人护理/化妆品、动物饲料、药品、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美硫酸软骨素市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲硫酸软骨素市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区硫酸软骨素市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲硫酸软骨素市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美硫酸软骨素市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球硫​​酸软骨素市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica SAU
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20627

The Global Chondroitin Sulfate Market is projected to expand from USD 1.11 Billion in 2025 to USD 1.35 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.32%. Chondroitin sulfate, a sulfated glycosaminoglycan, serves as a fundamental structural element of cartilage and is extensively used in pharmaceutical formulations and dietary supplements to maintain joint mobility and tissue integrity. The market is primarily propelled by an aging global population and the increasing incidence of osteoarthritis, which have accelerated a consumer shift toward preventative healthcare and non-invasive joint management. This demand is further supported by the widespread acceptance of nutritional strategies for physical well-being. As noted by the Consumer Healthcare Products Association in 2025, 83% of voters utilize dietary supplements to support their wellness needs, creating a highly favorable environment for joint health products.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.11 Billion
Market Size 2031USD 1.35 Billion
CAGR 2026-20313.32%
Fastest Growing SegmentAnimal Feed
Largest MarketAsia Pacific

Despite these positive growth indicators, the market faces a substantial obstacle due to its heavy dependence on animal-derived raw materials, particularly shark and bovine cartilage. This reliance exposes the industry to supply chain volatility and raises ethical objections among environmentally conscious consumers, limiting market reach in regions where vegan or plant-based preferences prevail. Additionally, the rigorous quality control necessary to prevent adulteration in animal-sourced supply chains increases manufacturing complexity and costs, which can hinder broader market accessibility.

Market Driver

The escalating prevalence of osteoarthritis and joint disorders stands as the primary factor driving the Global Chondroitin Sulfate Market. As degenerative cartilage conditions worsen globally, there is an urgent need for therapeutic agents that can inhibit degradative enzymes and stimulate proteoglycan synthesis. This health burden has established chondroitin sulfate as a cornerstone in pharmaceutical and nutraceutical management protocols. According to the study 'Global, regional, and national burdens of osteoarthritis from 1990 to 2021,' published in Frontiers in Medicine in November 2024, the global prevalence of osteoarthritis has reached approximately 606.9 million cases, creating a vast patient base reliant on joint preservation therapies. This demand is reinforced by a widespread reliance on nutritional interventions for physical wellness; the Council for Responsible Nutrition's '2024 Consumer Survey' from October 2024 indicates that 75% of Americans use dietary supplements, reflecting a consistent habit that benefits joint-health product categories.

A second critical driver expanding the market scope is the increasing demand for veterinary supplements and functional pet food. As pet owners continue to humanize their companions, there is a growing focus on managing feline and canine hip dysplasia through diet rather than invasive surgeries. Manufacturers are addressing this by fortifying premium kibble and treats with chondroitin to proactively handle orthopedic issues, extending the ingredient's application beyond human consumption. Data from the American Pet Products Association's '2024 Dog and Cat Report' in August 2024 shows that vitamin and supplement usage has increased by nearly 50% for dogs and 60% for cats since 2018. This surge diversifies revenue streams for ingredient producers, securing a strong position for chondroitin within the lucrative animal health sector.

Market Challenge

The significant reliance on animal-derived raw materials, particularly bovine and shark cartilage, presents a major challenge that restricts the growth of the global chondroitin sulfate market. This dependence ties manufacturers to the fluctuations of the fishing and meat processing industries, creating exposure to unpredictable raw material availability and supply chain volatility. Such instability hampers effective production planning and prevents the industry from establishing consistent pricing structures, which is detrimental to long-term reliability and commercial scalability.

Furthermore, the ethical implications and stringent quality assurance requirements associated with animal sourcing continue to impede market expansion. As consumers increasingly value sustainability, the sector struggles to penetrate demographics that prefer plant-based alternatives. Moreover, the mandatory testing required to ensure purity and prevent adulteration in animal-derived supply chains significantly raises manufacturing expenses. These increased operational costs lead to higher final product prices, limiting accessibility for price-sensitive consumers. According to the Council for Responsible Nutrition in 2024, 27% of non-users identified cost as a primary barrier to adopting supplements, highlighting how price inflation caused by these supply complexities directly curtails broader market penetration.

Market Trends

The Global Chondroitin Sulfate Market is being fundamentally reshaped by the accelerated adoption of vegan and fermentation-based production methods, driven by the need to mitigate supply chain risks linked to animal-derived sources. Manufacturers are rapidly transitioning from traditional shark and bovine cartilage extraction to advanced microbial fermentation technologies, which offer superior purity and consistency while addressing ethical consumer concerns. This technological shift is validated by significant improvements in efficacy among non-animal alternatives. According to Nutraceutical Business Review in April 2025, the 'MyCondro: a new name for a new era' report highlighted pharmacokinetic studies confirming that Gnosis by Lesaffre's fermentation-derived chondroitin sulfate demonstrated 45% higher bioavailability than standard bovine-derived ingredients, setting a new standard for premium joint health formulations.

The second major trend is the rise of synergistic formulations utilizing botanical extracts and collagen, as brands move beyond single-ingredient chondroitin supplements to offer comprehensive mobility solutions. Industry players are increasingly combining chondroitin sulfate with complementary ingredients like undenatured Type II collagen to enhance cartilage protection and enable lower effective dosages in finished products. This strategy aims to maximize therapeutic outcomes and differentiate products in a crowded market. As detailed by Bioiberica in November 2025 in the 'SupplySide Global 2025: Collavant n2 and joint health' update, a new clinical study revealed that their synergistic collagen ingredient resulted in a 40% improvement in cartilage preservation, underscoring the growing preference for multi-targeted joint health systems over standalone chondroitin therapies.

Key Market Players

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

Report Scope

In this report, the Global Chondroitin Sulfate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chondroitin Sulfate Market, By Source

  • Bovine
  • Poultry
  • Synthetic
  • Swine
  • Shark

Chondroitin Sulfate Market, By Application

  • Nutraceuticals
  • Personal Care & Cosmetics
  • Animal Feed
  • Pharmaceuticals
  • Others

Chondroitin Sulfate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chondroitin Sulfate Market.

Available Customizations:

Global Chondroitin Sulfate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chondroitin Sulfate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Bovine, Poultry, Synthetic, Swine, Shark)
    • 5.2.2. By Application (Nutraceuticals, Personal Care & Cosmetics, Animal Feed, Pharmaceuticals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Chondroitin Sulfate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chondroitin Sulfate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Chondroitin Sulfate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Chondroitin Sulfate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By Application

7. Europe Chondroitin Sulfate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chondroitin Sulfate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By Application
    • 7.3.2. France Chondroitin Sulfate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Chondroitin Sulfate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Chondroitin Sulfate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Chondroitin Sulfate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By Application

8. Asia Pacific Chondroitin Sulfate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chondroitin Sulfate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By Application
    • 8.3.2. India Chondroitin Sulfate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Chondroitin Sulfate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Chondroitin Sulfate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Chondroitin Sulfate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By Application

9. Middle East & Africa Chondroitin Sulfate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chondroitin Sulfate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Chondroitin Sulfate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Chondroitin Sulfate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By Application

10. South America Chondroitin Sulfate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chondroitin Sulfate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Chondroitin Sulfate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Chondroitin Sulfate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chondroitin Sulfate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. TSI Group Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Qingdao Wan Toulmin Biological Products Co., Ltd
  • 15.3. Hebei Sanxin Steel Structure Co Ltd
  • 15.4. Bioiberica S.A.U.
  • 15.5. Sigma-Aldrich, Inc.
  • 15.6. Sino Siam Biotechnique Company Limited
  • 15.7. Bio-gen Extracts Private Limited
  • 15.8. Zpd A/S
  • 15.9. SEIKAGAKU CORPORATION
  • 15.10. BRF SA

16. Strategic Recommendations

17. About Us & Disclaimer